Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion

Ophthalmic Research

Volumn 40, Issue 1, 2007, Pages 26-31

  Ozdek, Sengul ^a,b   Tiftikcioglu Deren, Yudum ^a   Gurelik, Gokhan ^a   Hasanreisoglu, Berati ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Branch retinal vein occlusion; Intravitreal triamcinolone; Macular grid laser photocoagulation; Posterior subtenon triamcinolone

Indexed keywords

TRIAMCINOLONE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA EDEMA; STUDENT T TEST; VISUAL ACUITY;

AGED; CONNECTIVE TISSUE; EYE; FEMALE; FOVEA CENTRALIS; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 37349123980     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111155     Document Type: Article

References (26)

1. The Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-282.
2. Ciulla TA, Walker JD, Fong DS, Criswell MH: Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Curr Opin Ophthalmol 2004;15:211-220.
3. Jonas J, Kreissig I, Sofker A, Degenring RF: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
4. Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoǧlu B: Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema. J Diabetes Complications 2006;20:246-251.
5. Antcliff RJ, Spalton DJ, Stanford MR, et al: Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-772.
6. Conway MD, Canakis C, Livir-Rallatos C, et al: Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 2003;29:27-33.
7. Greenberg PB, Martidis A, Rogers AH, et al: Intravitreal triamcinolone acetonide for macular edema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
8. Jonas JB, Kreissig I, Degenring RF: Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:782-783.
9. Özdek S, Aydin B, Gürelik G, et al: Effect of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion. Int J Ophthalmol 2005;26:27-34.
10. Jonas JB, Akkoyun I, Kampetter B, et al: Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 2005;19:65-71.
11. Yepremyan M, Wertz FD, Tivnan T, et al: Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2005;36:30-36.
12. Lee H, Shah GK: Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina 2005;25:551-555.
13. Hayashi K, Hayashi H: Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005;139:972-982.
14. Helm CJ, Holland GN: The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64.
15. Kalina PH, Erie JC, Rosenbaum L: Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol 1995;113:867-869.
16. Gutman FA, Zegarra H: The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974;78:78-192.
17. Tunc M, Onder HI, Kaya M: Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema. Ophthalmology 2005;112:1086-1091.
18. Jonas JB, Kreissig I, Degenring R: Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-27.
19. Jonas JB: Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res 2006;38:218-245.
20. Young S, Larkin C, Branley M, et al: Safety and the efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001;29:2-6.
21. Moshfeghi DM, Kaiser PK, Scott IU, et al: Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796.
22. Roth DB, Chich J, Spiru MJ, et al: Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-1282.
23. Ciulla TA, Walker JD, Fong DS, Criswell MH: Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Curr Opin Ophthalmol 2004;15:211-220.
24. Avitabile T, Longo A, Reibaldi A: Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005;140:695-702.
25. Erdinc A, Ozdek SC: Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2006;142:197.
26. Olk RJ, Akduman L: Minimal intensity diode laser (810 nanometer) photocoagulation (MIP) for diffuse diabetic macular edema (DDME). Semin Ophthalmol 2001;16:25-30.